Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
Publications found:
1,153
Sort by:
Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028
US$ 4,950.00
The gene therapy market is expected to reach USD 23.9 billion by 2028 from USD 9.0 billion in 2023, at a CAGR of 21.4% during the forecast period. The key factors driving the growth of the gene therap...
October 2023
276 pages
Dermatologicals in Austria
US$ 990.00
Over the forecast period dermatologicals in Austria is expected to benefit from an increasing number of people investing in beauty ... this is expected to particularly benefit beauty and per... Euromonitor International's Dermatologicals in Austria report offers a comprehensive guide to the size and shape of the ...
October 2023
26 pages
Dermatologicals in Singapore
US$ 990.00
... Series product range suited to eczema-prone... Euromonitor International's Dermatologicals in Singapore report offers a comprehensive guide to the size and ... Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical ...
October 2023
24 pages
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
US$ 3,217.50
... of novel hemofilters and their increasing use in CRRT procedures. “Continuous Venovenous Hemofiltration (CVVH) modality segment expected ... CRRT market is segmented into slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous ...
October 2023
226 pages
Dermatology Collaboration and Licensing Deals 2016-2023
US$ 3,995.00
... deals for the following indications: Acne, Actinic keratosis, Angioedema, Burns, Cellulitis, Cosmetics, Dermatitis, Diabetic foot ulcer, Eczema, Hair disorders, Alopecia, Impetigo, Itching, Nail disorders, Psoriasis, Rosacea, Scabies, Sun damage, Rash, Scar, Venous ulcer, Verruca, Wound healing, Wrinkles ...
October 2023
250 pages
CBD Skincare Market– Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Product Type (Creams, Moisturizers, Lotions, Balms, Serums, Face & Body Cleaners, Sunscreens, and Others), By Source Type (Hemp, Marijuana), By Distribution Channel (Supermarkets/Hypermarkets, Specialty Stores, Multi-Branded Stores, Pharmacy & Drug Stores, Online and Non-Retail), By Region, By Company
US$ 4,500.00
Global CBD skincare market is anticipated to grow during the forecast period due to the rising spending on skincare and a growing demand for herbal products. A non-intoxicating chemical called cannabi...
September 2023
185 pages
Global Crohn's Disease Therapeutics Market 2023
US$ 2,950.00
The market for therapeutics to treat Crohn's disease is projected to grow at a CAGR of 7.6% from 2023 to 2029, reaching USD 23.63 billion by 2029, compared to USD 13.86 billion in 2022. Crohn's diseas...
September 2023
88 pages
Aromatherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Component (Consumables v/s Diffusers), By Mode of Delivery (Topical Application, Aerial Diffusion, Direct Inhalation), By Distribution Channel (Direct-To-Consumer v/s B2B), By Application (Relaxation, Skin & Hair Care, Pain Management, Cold & Cough, Insomnia, Others), By End User (Hospitals & Clinics, Homecare, Spa & Wellness Centers, Others), By Region and Competition
US$ 4,500.00
Global aromatherapy market is anticipated to register a steady CAGR during the forecast period 2024-2028. This can be ascribed to increasing stress, anxiety, and depression among people caused by the...
August 2023
116 pages
Cell & Gene Therapy Drug Delivery Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Prefilled Syringe, Infusion Bags), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By Route of Administration (Oral, Intravenous, Ocular, Transdermal, Others), By Method (In Vitro v/s Ex Vivo), By Region and Competition
US$ 4,500.00
Global Cell & Gene Therapy Drug Delivery Devices market is expected to show robust growth in the forecast period, 2024-2028. This can be attributed to the growing use of cell and gene therapy for the...
August 2023
110 pages
Tuberculosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028FSegmented By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy (First Line Therapy, Second Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition
US$ 4,500.00
Global Tuberculosis Therapeutics Market is expected to grow at an impressive rate during the forecast period on account of the growing need to find new therapeutic solutions to combat the spread of tu...
August 2023
113 pages
RNA Vaccines and RNA Therapeutics Market: Distribution by Type of Modality (RNA Therapeutics and RNA Vaccines), Type of Molecule (replicating RNA, self amplifying RNA, self activating RNA, self amplifying mRNA and transfer RNA), Therapeutic Areas (Infectious Diseases, Oncological Disorders and Pulmonary Disorders), Route of Administration (Intradermal, Intramuscular and Intravenous), Key Geographical Regions (North America, Europe and Asia-Pacific) and Leading Players: Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global RNA Vaccines and RNA Therapeutics market is expected to reach USD 948 million by 2035 anticipated to grow at a CAGR of 50% during the forecast period 2026-2035. In recent years, RNA-based t...
August 2023
170 pages
Allogeneic Cell Therapy Market, 2023-2035 - Distribution by Type of Cell Therapy (Virus-Specific T-Cell, Stem Cell and Regulatory T-Cell), Source of Cell (Peripheral Blood, Bone Marrow, Umbilical Cord Blood, Adipose Tissue and Placenta), Target Indication (Bone Disorder, Critical Limb Ischemia, Crohn’s Disease, Diabetic Foot Ulcer, Graft versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndrome, Cytomegalovirus Infection, Others), Therapeutic Area (Oncological Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune / Inflammatory Disorders and Post-Transplant Infections), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts
US$ 4,799.00
The global allogenic cell therapy market is expected to reach USD 2.74 billion by 2023 and is anticipated to grow at a CAGR of 14.5% during the forecast period 2023-2035 Allogeneic cell therapies sign...
July 2023
222 pages
Cell and Gene Therapy Manufacturing Services Market
US$ 4,650.00
Report : The scope of this study encompasses an investigation of cell and gene therapy manufacturing services. BCC Research analyzes the manufacturing services based on therapy type, application, dise...
July 2023
138 pages
Global Dermatological Therapeutics Market 2023
US$ 975.00
Dermatological therapeutics encompasses the medical interventions and treatments used to address a wide range of skin conditions, including acne, eczema, psoriasis, dermatitis, skin infections, skin c...
June 2023
23 pages
Digital Therapeutics Market by Application (Mental health, Diabetes, Respiratory, Neurology, Gastrointestinal, Cardiovascular, Addiction, Rehabilitation, Oncology, Sleep Disorder), Type (Disease Prevention, Management), End User—Global Forecast to 2030
US$ 2,922.00
Digital Therapeutics Market by Application (Mental health, Diabetes, Respiratory, Neurology, Gastrointestinal, Cardiovascular, Addiction, Rehabilitation, Oncology, Sleep Disorder), Type (Disease Preve...
June 2023
197 pages
Epigenetic Therapeutics: Global Markets
US$ 4,650.00
Report : This report is a comprehensive study of the global market for epigenetic therapeutics. It describes the epigenetic therapeutics market, which is segmented by product type and region. Based on...
June 2023
155 pages
Urinary Tract Infection Therapeutics: By Indication (Complicated UTI, Uncomplicated UTI and Other), By Drug Type (Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitro furans and Other) And Region – Global Analysis of Market Size, Share & Trends for 2019–2020 And Forecasts to 2031
US$ 4,950.00
Urinary Tract Infection Therapeutics: By Indication (Complicated UTI, Uncomplicated UTI and Other), By Drug Type (Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitro furans and Other) And Regi...
May 2023
324 pages
Cell & Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication (Oncology, Orthopedic, Ophthalmology), Application (Clinical, Commercial), End User (Pharma, Biotech) - Global Forecast to 2027
US$ 3,217.50
The global cell & gene therapy manufacturing services market size is projected to reach USD 11.5 billion by 2027 from USD 5.1 billion in 2022, at a CAGR of 17.5% during the forecast period. Growth in...
January 2023
356 pages
Microbiome Therapeutics: Global Markets
US$ 2,500.00
Report : BCC Research’s new report, Microbiome Therapeutics: Global Markets, provides a comprehensive analysis of the microbiome therapeutics market in global context, including market forecasts and s...
January 2023
175 pages
Global TIL Therapy Market (2nd Edition), 2023-2035: Distribution by Target Indication (Melanoma, Head and Neck Carcinoma, Chronic Lymphocytic Leukemia, Sarcoma, Hepatocellular Carcinoma, Breast Cancer, Acute Myeloid Leukemia and Cervical Carcinoma), Key Players and Key Geographical Regions (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global TIL therapy market is expected to reach USD 0.09 billion in 2023 anticipated to grow at a CAGR of 40% during the forecast period 2023-2035. The global market for tumor infiltrating lymphocy...
January 2023
315 pages
Embolotherapy Global Market - Forecast to 2029
US$ 4,950.00
Embolotherapy involves the percutaneous endovascular use of one or more of a variety of agents and has evolved as a minimally invasive procedure for controlling blood loss during complicated surgical...
January 2023
449 pages
Exosome Therapy Market, Distribution by Type of Therapeutic (Allogeneic and Autologous), Target Indication (Degenerative Meniscal Injury, Dystrophic Epidermolysis Bullosa, Fistula Perianal and Retinitis Pigmentosa), Therapeutic Area (Dermatological Disorders, Musculoskeletal Disorders, Ophthalmic Diseases and Rectal Disorders), Route of Administration (Fistula Tract, Intra-articular and Intra-ocular) and Geography (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2040
US$ 4,799.00
The exosome therapy market in healthcare and pharmaceutical industry is expected to reach USD 32 million in 2022 and anticipated to grow at a CAGR of 41.2% during the forecast period 2023-2040. In rec...
January 2023
190 pages
Global TCR Therapy Market (2nd Edition), 2022-2035: Distribution by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The TCR therapy market is expected to reach USD 0.03 billion in 2023 anticipated to grow at a CAGR of 51% during the forecast period 2023-2035. T-cell receptor (TCR) based therapy is a burgeoning area...
January 2023
363 pages
Digital Therapeutics: A New Age Medicine
US$ 3,500.00
Report : The current report covers the booming technology of digital therapeutics. It also investigates the current shift in trends away from conventional methods of treatment toward the advanced mean...
November 2022
61 pages
Novel Antibody Therapy Market, 2022-2035: Distribution by Type of Novel Antibody (Immunocytokines, Immunotoxins and Radioisotope Immunoconjugates), Target Indication (Acute Myeloid Leukemia, Bladder Cancer, Diffuse Large B-cell Lymphoma, Graft-versus-host disease, Melanoma Prostate Cancer and Soft-tissue Sarcoma), Type of Therapy (Combination Therapy and Monotherapy), Route of Administration (Intratumoral, Intravenous and Intravesical), and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The novel antibody therapy market is expected to reach USD 2.4 billion in 2023 anticipated to grow at a CAGR of 36% during the forecast period 2022-2035. Cancer persists as a prominent cause of worldw...
September 2022
235 pages
Gene Therapy Market by Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts (5th Edition), 2022-2035
US$ 4,799.00
Gene Therapy Market (5th Edition) by Type of Therapy (Gene Augmentation, Oncolytic Viral Therapy, Immunotherapy and Others), Type of Gene Delivery Method Used (Ex vivo and In vivo), Type of Vector Use...
June 2022
865 pages
Global CAR T Cell Therapy Market & Clinical Trials Insight 2028
US$ 3,000.00
... CAR T Cell Therapies Clinical Pipeline by Company, Indication & Phase Global CAR T Cell Therapies Clinical Pipeline: 99 Therapies CAR T Cell Therapies in Highest Phase: Preregistration Majority of CAR T Cell Therapies in Phase-I/II Trials: 16 Therapies Global Market Scenario of CAR T Cell Therapy Global CAR ...
May 2022
720 pages
RNAi Therapeutics and Technology Market (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition) by Key Therapeutic Areas (Oncological Disorders, Genetic Disorders, Metabolic Disorders, Hematological Disorders, Ophthalmic Disorders and Other Disorders), Route of Administration (Subcutaneous, Intravenous, Topical and Intradermal), Leading Industry Players, Type of RNAi Molecule (siRNA and shRNA) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The projected value of RNAi therapeutics and technology market is expected to be valued at USD 1,200 million in 2022 and is anticipated to grow at a CAGR of 17% during the forecast period 2022-2035. R...
May 2022
421 pages
Global Next-Generation Antibody Therapeutics Market
US$ 4,950.00
Product Overview Use of a new improvised therapeutic antibody tform novel medicines for the treatment of different diseases includes next-generation antibody therapeutics. Next-generation antibody the...
April 2022
187 pages
Global CAR-T Cell Therapy Market, By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematological Malignancies, Solid Tumors), By Indication (Diffused Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Others), By Treatment Type (Single Treatment, Combination Treatment), By Targeted Antigen (CD 19, BCMA (B-Cell Maturation Antigen), Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition, Forecast and Opportunities, 2017-2027
US$ 4,500.00
Global CAR-T cell therapy market value in the year 2021 was valued at USD1709 million that is anticipated to grow with CAGR of 64.66% during the forecast period, 2023-2027 to achieve market value of U...
March 2022
283 pages
